相关实验视频

Updated: Jan 14, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

在慢性免疫介导的神经病变中使用免疫疗法

Chiara Briani¹, Andrea Visentin²

¹Department of Neurosciences, Neurology Unit, University of Padova, Padova, Italy.

Handbook of clinical neurology

|January 12, 2026

概括

针对慢性免疫介导神经病变,新疗法正在出现,针对特定的免疫反应. 这些包括影响补充通路和IgG循环的药物,为患有CIDP和抗MAG神经病变等疾病的患者提供了新的希望.

科学领域:

神经学神经学
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

慢性免疫介导神经病变传统上是用类固醇和免疫球蛋白治疗的.
最近的进展侧重于向免疫调节,以选择性地抑制异常免疫反应.

研究的目的:

审查慢性免疫介导神经病变的新兴治疗点和治疗方法.
突出作用于补充通路的新药和通过新生儿Fc受体 (FcRn) 的IgG循环.

主要方法:

对免疫介导神经病变的当前和试验性治疗方法的审查.
专注于针对FcRn,补充通路和B细胞信号的药物.

主要成果:

针对FcRn的Efgartigimod已被批准用于慢性炎症性脱髓化多基原蛋白神经病变 (CIDP).
利图西马布在CIDP中表现有前途,并用于抗髓关联糖蛋白 (MAG) 抗体神经病变.
ARGX-117 (抗C2补充剂) 正在针对多焦点运动神经病变进行调查.
布鲁顿的氨酸激酶抑制剂 (扎努布鲁丁尼布,阿卡拉布鲁丁尼布) 正在测试抗MAG抗体神经病变.

结论:

新型向疗法正在扩大慢性免疫介导神经病变的治疗选择.
药物如efgartigimod,rituximab和研究药物在CIDP和抗MAG神经病变等疾病中提供了改善结果的潜力.

关键词:

抗MAG神经病变是一种神经病变.这是一种BTK抑制剂.在CIDP中,我们可以看到CIDP.慢性免疫介导的神经病变在Efgartigimod中使用.在FcRnnn中.多焦点运动神经病变副蛋白质性神经病变是什么?里图西马布 (Rituximab) 是一种药物.

更多相关视频

In Vitro Myelination of Peripheral Axons in a Coculture of Rat Dorsal Root Ganglion Explants and Schwann Cells

In Vitro Myelination of Peripheral Axons in a Coculture of Rat Dorsal Root Ganglion Explants and Schwann Cells

Published on: February 10, 2023

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...